|

Insights on Dissemination of Lung Cancer

RECRUITINGSponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna
Actively Recruiting
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Started2026-02-01
Est. completion2029-02-01
Eligibility
Age18 Years+
View on ClinicalTrials.gov →

NCT07476495

Summary

In patients with resectable NSCLC treated with surgery alone or with surgery as part of a multimodal treatment; CTC, ctDNA, STAS, and lymph node micrometastasis levels will be evaluated to see if they are associated with recurrence patterns and long-term outcomes.

Eligibility

Age: 18 Years+
Inclusion Criteria:

* Age ≥ 18 years;
* Preoperative diagnosis of resectable stage cIA-cIIIA NSCLC (adenocarcinoma or squamous cell carcinoma);
* Patients deemed fit for surgical or multimodal treatment;
* Informed consent obtained;
* Treatment, including multimodal treatment, involving surgery.

Exclusion Criteria:

* Histology other than adenocarcinoma or squamous cell carcinoma;
* Other neoplastic diseases concurrent with or undergoing treatment or treated with systemic therapies in the previous three years;
* Age \<18 years;
* No need for surgery.

Conditions3

CancerLung CancerOncology & Epidemiology & Lung Cancer

Browse More Trials

Cancer trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.